Progress Towards a Reality: A Diagnostic Test for Long COVID
Imagine a world where a simple blood test could reveal whether you’re battling Long COVID or not? Well, the world of science is getting closer to making this a reality.
COVID-19 is a disease that not only can inflict multiorgan symptoms or damage during the acute phase of infection, but also can carry the potential for enduring consequences, manifesting as part of post-acute sequelae of SARS-CoV-2 infection (PASC) or the long-COVID syndrome.
Long COVID represents a complex spectrum of symptoms that may persist long after the initial COVID-19 infection has cleared.
Those individuals experiencing long COVID often describe lingering symptoms such as persistent “brain fog,” chronic fatigue, headaches, post-exertional malaise, numbness/tingling sensations, altered taste sensations, loss of smell, muscle pain, and a range of other cognitive and autonomic dysfunctions.
In this evolving landscape of understanding long COVID, advancements in diagnostic tools, like blood tests, are promising steps towards better identification and management of this challenging new condition.
From Patients to Promising Results
A recent cross-sectional study published in Nature has identified specific biomarkers in the blood of individuals with Long COVID. This breakthrough could potentially pave the way for the development of blood tests aimed at accurately identifying presence of long COVID, thus enabling the application of tailored treatments.
The study, conducted by researchers from the Icahn School of Medicine at Mount Sinai and Yale School of Medicine, involved the analysis of blood samples obtained from 273 individuals between January 2021 and June 2022. These individuals either had no prior history of COVID infection, had fully recovered from a previous infection, or were still experiencing symptoms at least four months post-infection.
Utilizing machine learning techniques, the researchers achieved a remarkable 96% accuracy rate in distinguishing between individuals with long COVID and those without it, based on distinctive patterns observed in the blood samples.
A Puzzling Twist: Clues to Long COVID and Reactivation of Dormant Viruses
The study revealed that individuals with long COVID displayed abnormal T cell activity and reduced levels of the hormone cortisol. The decreased levels of cortisol were among the key factors that clearly differentiated individuals with long COVID from those without the condition.
Cortisol, widely known as the “stress hormone,” is responsible for promoting alertness and wakefulness, mediating the stress response, regulating metabolism, the inflammatory response, and the immune function.
A notable discovery within this study was that long COVID may reactivate latent viruses, such as Epstein-Barr and mononucleosis. These latent viral reactivations pose an additional layer of complexity to the long COVID condition.
The potential implications of these blood tests are substantial. They could enable healthcare professionals to devise specialized treatments for individuals reporting a wide array of long COVID symptoms.
According to the CDC, approximately one in five Americans who have had COVID continue to experience long COVID symptoms, which encompass chronic fatigue, cognitive impairment, dizziness, gastrointestinal issues, and a loss or change of smell and taste.
